In this video, Dr. Paz-Ares discusses a phase III study that showed that nivolumab improved survival and response rates in previously treated patients with metastatic non-squamous non-small-cell lung cancer (NSCLC).
Luis Paz-Ares, MD
Advertisement
Articles by Luis Paz-Ares, MD
Advertisement
Latest Updated Articles
Nivolumab Effective in Advanced Non-Squamous NSCLCPublished: June 10th 2015 | Updated: November 11th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC
2
ctDNA Clearance Correlates With Improved Metastasis-Free Survival in MIBC
3
Enfortumab Vedotin Combo Boosts MIBC Survival Outcomes in EV-304 Trial
4
Lessons From the Withdrawal of Atezolizumab in Metastatic TNBC
5